Health Care & Life Sciences » Biotechnology | Omni Bio Pharmaceutical Inc.

Omni Bio Pharmaceutical Inc.

Omni Bio Pharmaceutical Inc.
Stock Exchange Other OTC
EPS
-
Market Cap
$1.63 M
Shares Outstanding
50.06 M
Public Float
-

Profile

Address
181 West Boardwalk Drive
Fort Collins Colorado 80525
United States
Employees -
Website http://www.omnibiopharma.com
Updated 07/08/2019
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company, which engaes in the exploration of new methods of use of alpha-1 antitrypsin (AAT). It offers AAT, a naurally occurring protein that is essential for normal liver and lung function and has been purified from human blood to treat patients suffering from emphysema due to AAT-deficiency. The company was founded on December 1, 2005 and is headquartered in Fort Collins, CO.

Financials

View All
Created with Highcharts 5.0.14Omni Bio Pharmaceutical Inc.Net Income. Fiscal year is April-March. All values USD Thousands.5 0255 0258 2258 2255 3955 3957 4547 4542 5162 5162010201120122013201402k4k6k8k10k

John F. Riccardi
Chief Financial Officer & Director
John F. Riccardi
Chief Financial Officer & Director